Cite
MLA Citation
Franck E Nicolini et al.. “Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.” Lancet, vol. 2, no. 1, 2015, pp. e37–e46. http://access.bl.uk/ark:/81055/vdc_100066540074.0x000008